Feb 17 2010
APCER 
      PHARMA (“APCER”) executives will discuss and demonstrate their 
      expertise in providing generic drug manufacturers with the best in class 
      pharmacovigilance/drug safety, regulatory and risk management services 
      at the GPhA Annual Meeting, February 16-18, at the Ritz-Carlton in 
      Naples, Florida. APCER will be in Booth #27.
    
“APCER is repeatedly 
      chosen as the safety and regulatory services provider by pharmaceutical 
      companies because our team knows what it takes to provide a compliant, 
      best in class solution, at a very effective price.”
    
      APCER is a leading global provider of comprehensive 
      drug safety, regulatory services and risk management programs for pharmaceutical, 
      biotechnology, medical device and consumer products companies.
    
    
      APCER President and CEO Suneet Walia explained, “APCER is repeatedly 
      chosen as the safety and regulatory services provider by pharmaceutical 
      companies because our team knows what it takes to provide a compliant, 
      best in class solution, at a very effective price.”
    
    
      APCER uses leading systems on a secure, hosted platform to handle 
      customers’ requirements at virtually a fraction of the cost of what it 
      would normally cost a company to implement their own system. The team at 
      APCER is experienced and the operations truly global. APCER currently 
      does case reporting on behalf of its clients in 68 countries and has a 
      team on the ground in North America, Europe and Asia that works closely 
      with its customers to provide round the clock service.